Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jul. 02, 2023	Jun. 30, 2024	Jul. 02, 2023
Sales by segment of business
Sales to customers	$ 22,447	$ 21,519	$ 43,830	$ 42,413
Percent Change (as a percent)	4.30%		3.30%
U.S.
Sales by segment of business
Sales to customers	$ 12,569	11,657	$ 24,189	22,439
Percent Change (as a percent)	7.80%		7.80%
International
Sales by segment of business
Sales to customers	$ 9,878	9,862	$ 19,641	19,974
Percent Change (as a percent)	0.20%		(1.70%)
MEDTECH
Sales by segment of business
Sales to customers	$ 7,957	7,788	$ 15,778	15,269
Percent Change (as a percent)	2.20%		3.30%
MEDTECH | U.S.
Sales by segment of business
Sales to customers	$ 4,059	3,839	$ 8,067	7,598
Percent Change (as a percent)	5.70%		6.20%
MEDTECH | International
Sales by segment of business
Sales to customers	$ 3,898	3,949	$ 7,711	7,671
Percent Change (as a percent)	(1.30%)		0.50%
MEDTECH | Cardiovascular(1)
Sales by segment of business
Sales to customers	$ 1,873	1,620	$ 3,679	3,123
Percent Change (as a percent)	15.60%		17.80%
MEDTECH | Cardiovascular(1) | U.S.
Sales by segment of business
Sales to customers	$ 1,119	908	$ 2,144	1,771
Percent Change (as a percent)	23.30%		21.10%
MEDTECH | Cardiovascular(1) | International
Sales by segment of business
Sales to customers	$ 753	712	$ 1,534	1,352
Percent Change (as a percent)	5.70%		13.40%
MEDTECH | ELECTROPHYSIOLOGY
Sales by segment of business
Sales to customers	$ 1,323	1,196	$ 2,667	2,288
Percent Change (as a percent)	10.60%		16.50%
MEDTECH | ELECTROPHYSIOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 705	609	$ 1,397	1,180
Percent Change (as a percent)	15.70%		18.40%
MEDTECH | ELECTROPHYSIOLOGY | International
Sales by segment of business
Sales to customers	$ 618	587	$ 1,270	1,109
Percent Change (as a percent)	5.40%		14.60%
MEDTECH | ABIOMED
Sales by segment of business
Sales to customers	$ 379	331	$ 750	655
Percent Change (as a percent)	14.50%		14.50%
MEDTECH | ABIOMED | U.S.
Sales by segment of business
Sales to customers	$ 309	272	$ 612	536
Percent Change (as a percent)	13.20%		14.10%
MEDTECH | ABIOMED | International
Sales by segment of business
Sales to customers	$ 72	59	$ 139	119
Percent Change (as a percent)	20.70%		16.50%
MEDTECH | Shockwave
Sales by segment of business
Sales to customers	$ 77	0	$ 77	0
MEDTECH | Shockwave | U.S.
Sales by segment of business
Sales to customers	77	0	77	0
MEDTECH | Shockwave | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
MEDTECH | OTHER CARDIOVASCULAR(1)
Sales by segment of business
Sales to customers	$ 93	93	$ 185	180
Percent Change (as a percent)	0.30%		2.90%
MEDTECH | OTHER CARDIOVASCULAR(1) | U.S.
Sales by segment of business
Sales to customers	$ 29	27	$ 59	55
Percent Change (as a percent)	12.50%		7.70%
MEDTECH | OTHER CARDIOVASCULAR(1) | International
Sales by segment of business
Sales to customers	$ 64	67	$ 126	125
Percent Change (as a percent)	(4.50%)		0.80%
MEDTECH | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,312	2,265	$ 4,652	4,510
Percent Change (as a percent)	2.10%		3.20%
MEDTECH | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,422	1,388	$ 2,870	2,751
Percent Change (as a percent)	2.50%		4.30%
MEDTECH | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 890	878	$ 1,782	1,759
Percent Change (as a percent)	1.40%		1.30%
MEDTECH | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 417	397	$ 839	787
Percent Change (as a percent)	4.90%		6.50%
MEDTECH | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 265	250	$ 535	491
Percent Change (as a percent)	5.80%		8.90%
MEDTECH | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 152	147	$ 304	296
Percent Change (as a percent)	3.40%		2.60%
MEDTECH | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 394	363	$ 795	731
Percent Change (as a percent)	8.40%		8.70%
MEDTECH | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 230	221	$ 472	447
Percent Change (as a percent)	4.20%		5.50%
MEDTECH | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 163	142	$ 323	284
Percent Change (as a percent)	14.90%		13.60%
MEDTECH | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 759	739	$ 1,524	1,496
Percent Change (as a percent)	2.80%		1.90%
MEDTECH | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 498	483	$ 1,002	974
Percent Change (as a percent)	3.00%		2.90%
MEDTECH | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 260	255	$ 521	522
Percent Change (as a percent)	2.40%		0.00%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 743	766	$ 1,495	1,495
Percent Change (as a percent)	(3.10%)		0.00%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 430	433	$ 862	839
Percent Change (as a percent)	(0.80%)		2.70%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 314	334	$ 634	657
Percent Change (as a percent)	(6.10%)		(3.50%)
MEDTECH | Surgery
Sales by segment of business
Sales to customers	$ 2,488	2,594	$ 4,904	5,028
Percent Change (as a percent)	(4.10%)		(2.50%)
MEDTECH | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 995	1,015	$ 1,982	1,990
Percent Change (as a percent)	(2.00%)		(0.40%)
MEDTECH | Surgery | International
Sales by segment of business
Sales to customers	$ 1,493	1,580	$ 2,922	3,039
Percent Change (as a percent)	(5.50%)		(3.80%)
MEDTECH | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,141	1,222	$ 2,228	2,340
Percent Change (as a percent)	(6.70%)		(4.80%)
MEDTECH | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 466	466	$ 912	910
Percent Change (as a percent)	0.10%		0.20%
MEDTECH | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 675	757	$ 1,316	1,430
Percent Change (as a percent)	(10.80%)		(8.00%)
MEDTECH | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,346	1,372	$ 2,676	2,688
Percent Change (as a percent)	(1.90%)		(0.50%)
MEDTECH | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 528	548	$ 1,070	1,079
Percent Change (as a percent)	(3.70%)		(0.90%)
MEDTECH | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 818	823	$ 1,606	1,608
Percent Change (as a percent)	(0.70%)		(0.20%)
MEDTECH | Vision
Sales by segment of business
Sales to customers	$ 1,285	1,308	$ 2,543	2,608
Percent Change (as a percent)	(1.70%)		(2.50%)
MEDTECH | Vision | U.S.
Sales by segment of business
Sales to customers	$ 523	529	$ 1,070	1,087
Percent Change (as a percent)	(1.20%)		(1.50%)
MEDTECH | Vision | International
Sales by segment of business
Sales to customers	$ 763	778	$ 1,473	1,521
Percent Change (as a percent)	(2.00%)		(3.20%)
MEDTECH | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 918	939	$ 1,828	1,892
Percent Change (as a percent)	(2.20%)		(3.40%)
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 409	409	$ 847	853
Percent Change (as a percent)	0.20%		(0.60%)
MEDTECH | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 509	530	$ 981	1,039
Percent Change (as a percent)	(4.00%)		(5.60%)
MEDTECH | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 367	369	$ 715	716
Percent Change (as a percent)	(0.50%)		(0.10%)
MEDTECH | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 113	120	$ 223	234
Percent Change (as a percent)	(5.80%)		(4.80%)
MEDTECH | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 254	249	$ 492	482
Percent Change (as a percent)	2.10%		2.10%
Innovative Medicine
Sales by segment of business
Sales to customers	$ 14,490	13,731	$ 28,052	27,144
Percent Change (as a percent)	5.50%		3.30%
Innovative Medicine | U.S.
Sales by segment of business
Sales to customers	$ 8,510	7,818	$ 16,122	14,841
Percent Change (as a percent)	8.90%		8.60%
Innovative Medicine | International
Sales by segment of business
Sales to customers	$ 5,980	5,913	$ 11,930	12,303
Percent Change (as a percent)	1.10%		(3.00%)
Innovative Medicine | Immunology
Sales by segment of business
Sales to customers	$ 4,722	4,496	$ 8,969	8,608
Percent Change (as a percent)	5.00%		4.20%
Innovative Medicine | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 2,978	2,865	$ 5,431	5,313
Percent Change (as a percent)	4.00%		2.20%
Innovative Medicine | Immunology | International
Sales by segment of business
Sales to customers	$ 1,744	1,631	$ 3,538	3,295
Percent Change (as a percent)	6.90%		7.40%
Innovative Medicine | Immunology | REMICADE
Sales by segment of business
Sales to customers	$ 393	462	$ 827	949
Percent Change (as a percent)	(14.90%)		(12.90%)
Innovative Medicine | Immunology | REMICADE | U.S.
Sales by segment of business
Sales to customers	$ 231	277	$ 497	553
Percent Change (as a percent)	(16.70%)		(10.10%)
Innovative Medicine | Immunology | REMICADE | U.S. Exports
Sales by segment of business
Sales to customers	$ 35	33	$ 62	74
Percent Change (as a percent)	7.90%		(15.40%)
Innovative Medicine | Immunology | REMICADE | International
Sales by segment of business
Sales to customers	$ 127	152	$ 268	322
Percent Change (as a percent)	(16.60%)		(16.90%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA
Sales by segment of business
Sales to customers	$ 537	529	$ 1,091	1,066
Percent Change (as a percent)	1.60%		2.30%
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | U.S.
Sales by segment of business
Sales to customers	$ 267	285	$ 521	556
Percent Change (as a percent)	(6.30%)		(6.20%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | International
Sales by segment of business
Sales to customers	$ 270	244	$ 569	510
Percent Change (as a percent)	10.90%		11.70%
Innovative Medicine | Immunology | STELARA
Sales by segment of business
Sales to customers	$ 2,885	2,797	$ 5,336	5,241
Percent Change (as a percent)	3.10%		1.80%
Innovative Medicine | Immunology | STELARA | U.S.
Sales by segment of business
Sales to customers	$ 1,855	1,817	$ 3,251	3,268
Percent Change (as a percent)	2.10%		(0.50%)
Innovative Medicine | Immunology | STELARA | International
Sales by segment of business
Sales to customers	$ 1,030	981	$ 2,085	1,974
Percent Change (as a percent)	5.00%		5.60%
Innovative Medicine | Immunology | TREMFYA
Sales by segment of business
Sales to customers	$ 906	706	$ 1,714	1,346
Percent Change (as a percent)	28.30%		27.30%
Innovative Medicine | Immunology | TREMFYA | U.S.
Sales by segment of business
Sales to customers	$ 589	450	$ 1,098	856
Percent Change (as a percent)	30.80%		28.20%
Innovative Medicine | Immunology | TREMFYA | International
Sales by segment of business
Sales to customers	$ 317	255	$ 616	489
Percent Change (as a percent)	23.90%		25.80%
Innovative Medicine | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 2	4	$ 2	7
Percent Change (as a percent)	(51.50%)		(75.40%)
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 2	4	$ 2	7
Percent Change (as a percent)	(51.50%)		(75.40%)
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
Innovative Medicine | Infectious Diseases
Sales by segment of business
Sales to customers	$ 965	1,121	$ 1,786	2,707
Percent Change (as a percent)	(13.90%)		(34.00%)
Innovative Medicine | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 334	395	$ 658	787
Percent Change (as a percent)	(15.40%)		(16.40%)
Innovative Medicine | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 631	727	$ 1,128	1,920
Percent Change (as a percent)	(13.10%)		(41.30%)
Innovative Medicine | Infectious Diseases | COVID-19
Sales by segment of business
Sales to customers	$ 172	285	$ 197	1,032
Percent Change (as a percent)	(39.70%)		(80.90%)
Innovative Medicine | Infectious Diseases | COVID-19 | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
Innovative Medicine | Infectious Diseases | COVID-19 | International
Sales by segment of business
Sales to customers	$ 172	285	$ 197	1,032
Percent Change (as a percent)	(39.70%)		(80.90%)
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine
Sales by segment of business
Sales to customers	$ 297	266	$ 620	546
Percent Change (as a percent)	11.00%		13.40%
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 8	8	$ 16	17
Percent Change (as a percent)	(2.80%)		(7.00%)
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | International
Sales by segment of business
Sales to customers	$ 288	258	$ 603	529
Percent Change (as a percent)	11.50%		14.10%
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA
Sales by segment of business
Sales to customers	$ 438	491	$ 856	968
Percent Change (as a percent)	(11.00%)		(11.60%)
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.
Sales by segment of business
Sales to customers	$ 321	382	$ 635	760
Percent Change (as a percent)	(16.00%)		(16.50%)
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International
Sales by segment of business
Sales to customers	$ 117	109	$ 221	208
Percent Change (as a percent)	6.50%		6.00%
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES(
Sales by segment of business
Sales to customers	$ 61	79	$ 114	161
Percent Change (as a percent)	(23.10%)		(29.30%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES( | U.S.
Sales by segment of business
Sales to customers	$ 5	5	$ 7	10
Percent Change (as a percent)	18.50%		(29.40%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES( | International
Sales by segment of business
Sales to customers	$ 55	74	$ 107	151
Percent Change (as a percent)	(25.60%)		(29.30%)
Innovative Medicine | Neuroscience
Sales by segment of business
Sales to customers	$ 1,782	1,793	$ 3,585	3,597
Percent Change (as a percent)	(0.60%)		(0.30%)
Innovative Medicine | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 1,102	1,029	$ 2,156	2,007
Percent Change (as a percent)	7.10%		7.40%
Innovative Medicine | Neuroscience | International
Sales by segment of business
Sales to customers	$ 679	764	$ 1,428	1,590
Percent Change (as a percent)	(11.10%)		(10.20%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate
Sales by segment of business
Sales to customers	$ 163	208	$ 340	414
Percent Change (as a percent)	(21.50%)		(17.80%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 34	64	$ 75	134
Percent Change (as a percent)	(47.70%)		(44.30%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | International
Sales by segment of business
Sales to customers	$ 129	143	$ 265	279
Percent Change (as a percent)	(9.80%)		(5.10%)
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA
Sales by segment of business
Sales to customers	$ 1,054	1,031	$ 2,110	2,075
Percent Change (as a percent)	2.20%		1.70%
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.
Sales by segment of business
Sales to customers	$ 784	721	$ 1,549	1,434
Percent Change (as a percent)	8.80%		8.00%
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International
Sales by segment of business
Sales to customers	$ 269	310	$ 561	641
Percent Change (as a percent)	(13.10%)		(12.40%)
Innovative Medicine | Neuroscience | SPRAVATO
Sales by segment of business
Sales to customers	$ 271	169	$ 496	300
Percent Change (as a percent)	60.20%		65.50%
Innovative Medicine | Neuroscience | SPRAVATO | U.S.
Sales by segment of business
Sales to customers	$ 226	144	$ 417	255
Percent Change (as a percent)	57.90%		63.90%
Innovative Medicine | Neuroscience | SPRAVATO | International
Sales by segment of business
Sales to customers	$ 44	25	$ 78	45
Percent Change (as a percent)	73.50%		74.60%
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 294	386	$ 639	809
Percent Change (as a percent)	(23.70%)		(21.00%)
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 57	100	$ 115	184
Percent Change (as a percent)	(42.50%)		(37.30%)
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 237	286	$ 524	625
Percent Change (as a percent)	(17.00%)		(16.20%)
Innovative Medicine | Oncology
Sales by segment of business
Sales to customers	$ 5,090	4,398	$ 9,904	8,510
Percent Change (as a percent)	15.70%		16.40%
Innovative Medicine | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 2,636	2,069	$ 5,019	3,958
Percent Change (as a percent)	27.40%		26.80%
Innovative Medicine | Oncology | International
Sales by segment of business
Sales to customers	$ 2,455	2,329	$ 4,885	4,552
Percent Change (as a percent)	5.40%		7.30%
Innovative Medicine | Oncology | CARVYKTI
Sales by segment of business
Sales to customers	$ 186	117	$ 343	189
Percent Change (as a percent)	59.80%		81.50%
Innovative Medicine | Oncology | CARVYKTI | U.S.
Sales by segment of business
Sales to customers	$ 167	114	$ 307	184
Percent Change (as a percent)	46.50%		66.80%
Innovative Medicine | Oncology | CARVYKTI | International
Sales by segment of business
Sales to customers	$ 20	3	$ 36	5
Innovative Medicine | Oncology | DARZALEX
Sales by segment of business
Sales to customers	$ 2,878	2,431	$ 5,570	4,695
Percent Change (as a percent)	18.40%		18.60%
Innovative Medicine | Oncology | DARZALEX | U.S.
Sales by segment of business
Sales to customers	$ 1,641	1,322	$ 3,105	2,513
Percent Change (as a percent)	24.20%		23.60%
Innovative Medicine | Oncology | DARZALEX | International
Sales by segment of business
Sales to customers	$ 1,237	1,110	$ 2,465	2,182
Percent Change (as a percent)	11.50%		12.90%
Innovative Medicine | Oncology | ERLEADA
Sales by segment of business
Sales to customers	$ 736	567	$ 1,425	1,109
Percent Change (as a percent)	29.80%		28.40%
Innovative Medicine | Oncology | ERLEADA | U.S.
Sales by segment of business
Sales to customers	$ 318	241	$ 603	490
Percent Change (as a percent)	32.20%		23.00%
Innovative Medicine | Oncology | ERLEADA | International
Sales by segment of business
Sales to customers	$ 418	326	$ 822	619
Percent Change (as a percent)	28.00%		32.80%
Innovative Medicine | Oncology | IMBRUVICA
Sales by segment of business
Sales to customers	$ 770	841	$ 1,554	1,668
Percent Change (as a percent)	(8.50%)		(6.90%)
Innovative Medicine | Oncology | IMBRUVICA | U.S.
Sales by segment of business
Sales to customers	$ 246	262	$ 511	532
Percent Change (as a percent)	(6.40%)		(3.90%)
Innovative Medicine | Oncology | IMBRUVICA | International
Sales by segment of business
Sales to customers	$ 525	579	$ 1,043	1,136
Percent Change (as a percent)	(9.40%)		(8.30%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate
Sales by segment of business
Sales to customers	$ 165	227	$ 346	472
Percent Change (as a percent)	(27.70%)		(26.80%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 11	9	$ 20	25
Percent Change (as a percent)	21.60%		(19.70%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 154	218	$ 326	447
Percent Change (as a percent)	(29.60%)		(27.20%)
Innovative Medicine | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 221	120	$ 399	219
Percent Change (as a percent)	84.20%		82.40%
Innovative Medicine | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 148	40	$ 267	75
Innovative Medicine | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 71	80	$ 131	144
Percent Change (as a percent)	(10.40%)		(8.50%)
Innovative Medicine | Oncology | Tecvayli
Sales by segment of business
Sales to customers	$ 135	94	$ 268	157
Percent Change (as a percent)	42.90%		70.20%
Innovative Medicine | Oncology | Tecvayli | U.S.
Sales by segment of business
Sales to customers	$ 104	82	$ 205	139
Percent Change (as a percent)	27.50%		47.70%
Innovative Medicine | Oncology | Tecvayli | International
Sales by segment of business
Sales to customers	$ 30	12	$ 63	18
Innovative Medicine | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 1,039	972	$ 2,088	1,844
Percent Change (as a percent)	6.90%		13.20%
Innovative Medicine | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 743	684	$ 1,509	1,284
Percent Change (as a percent)	8.70%		17.50%
Innovative Medicine | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 296	289	$ 579	561
Percent Change (as a percent)	2.60%		3.40%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT
Sales by segment of business
Sales to customers	$ 544	507	$ 1,068	947
Percent Change (as a percent)	7.10%		12.70%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | U.S.
Sales by segment of business
Sales to customers	$ 373	328	$ 729	601
Percent Change (as a percent)	13.70%		21.30%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | International
Sales by segment of business
Sales to customers	$ 170	179	$ 339	346
Percent Change (as a percent)	(5.00%)		(2.20%)
Innovative Medicine | Pulmonary Hypertension | UPTRAVI
Sales by segment of business
Sales to customers	$ 426	399	$ 894	761
Percent Change (as a percent)	6.60%		17.40%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | U.S.
Sales by segment of business
Sales to customers	$ 349	338	$ 741	642
Percent Change (as a percent)	3.30%		15.50%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | International
Sales by segment of business
Sales to customers	$ 76	61	$ 152	119
Percent Change (as a percent)	24.60%		27.60%
Innovative Medicine | Pulmonary Hypertension | Other
Sales by segment of business
Sales to customers	$ 71	66	$ 127	136
Percent Change (as a percent)	7.20%		(6.50%)
Innovative Medicine | Pulmonary Hypertension | Other | U.S.
Sales by segment of business
Sales to customers	$ 20	18	$ 38	41
Percent Change (as a percent)	18.80%		(6.10%)
Innovative Medicine | Pulmonary Hypertension | Other | International
Sales by segment of business
Sales to customers	$ 50	48	$ 89	95
Percent Change (as a percent)	3.10%		(6.70%)
Innovative Medicine | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 892	950	$ 1,721	1,877
Percent Change (as a percent)	(6.20%)		(8.30%)
Innovative Medicine | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 717	776	$ 1,348	1,491
Percent Change (as a percent)	(7.70%)		(9.60%)
Innovative Medicine | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 176	174	$ 373	386
Percent Change (as a percent)	0.60%		(3.60%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other
Sales by segment of business
Sales to customers	$ 305	313	$ 616	662
Percent Change (as a percent)	(2.50%)		(7.00%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | U.S.
Sales by segment of business
Sales to customers	$ 129	138	$ 243	275
Percent Change (as a percent)	(6.40%)		(11.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | International
Sales by segment of business
Sales to customers	$ 176	174	$ 373	386
Percent Change (as a percent)	0.60%		(3.60%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO
Sales by segment of business
Sales to customers	$ 587	637	$ 1,105	1,215
Percent Change (as a percent)	(7.90%)		(9.10%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | U.S.
Sales by segment of business
Sales to customers	$ 587	637	$ 1,105	1,215
Percent Change (as a percent)	(7.90%)		(9.10%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | International
Sales by segment of business
Sales to customers	$ 0	$ 0	$ 0	$ 0
Percent Change (as a percent)	0.00%		0.00%